Guomao Health Tech Acquires PRT Medical to Accelerate Strategic Expansion in Minimally Invasive Surgical Devices

On June 29, Beijing Pert Medical Technology Co., Ltd. (hereinafter referred to as “Pert Medical”) held a shareholders’ meeting and completed the re-election of its board of directors. This marks the completion of Xiamen ITG Health Technology Co., Ltd. (hereinafter referred to as “ITG Health Tech”), a subsidiary of Xiamen ITG Group Corp., Ltd., in acquiring Pert Medical, effectively advancing ITG Health Tech’s strategic layout in the medical device sector.

In recent years, the market size of China’s medical device industry has continued to grow. Driven by policy support, capital investment, and market demand, domestically produced medical devices have achieved breakthrough progress. The domestic medical device supply chain is becoming increasingly mature, accelerating the development pattern of “domestic substitution + independent innovation.” Among various sectors, minimally invasive surgery boasts broad development prospects and is one of the hottest tracks attracting significant attention from both the market and investors. Minimally invasive surgical instruments encompass a wide range of categories, primarily including staplers, ultrasonic scalpels for cutting and hemostasis, trocars, and polymer and metal ligation clips, with the market size maintaining a high growth rate in recent years.

After more than two decades of development, Pelt Medical has established a comprehensive business system centered on minimally invasive surgical instruments, with balanced growth across other surgical device categories. Its product portfolio spans six key areas: staplers, energy-based surgical devices, sutures, hand-held instruments, biomaterials, and hernia repair products, with over 100 products having obtained domestic and international certifications.

Purui Medical adheres to the corporate philosophy of “Exploration Rooted in Care, Quality Driven by Heart,” continuously pioneering and innovating in the field of research and development. In 2013, its independently developed disposable endoscopic cutting stapler was awarded the Second Prize of the National Science and Technology Progress Award, and this product has since become the company’s flagship offering. In 2020, Purui Medical invested nearly RMB 100 million to incubate a high-performance minimally invasive endoscopic robotic system, which integrates dozens of self-developed consumables. This system received the Second Prize of the National Technological Invention Award and is poised to enter clinical trials. In 2021, Purui Medical’s intelligent endoscopic stapler obtained approval as an innovative medical device from the Beijing Medical Products Administration. Building upon iterative innovations of manual endoscopic staplers and integrating five invention patents, this product became the world’s first fully disposable intelligent stapler with a built-in MCU chip, enabling functionalities such as chip identification, tissue detection, and intelligent firing control.

While prioritizing R&D innovation, Pault Medical boasts extensive global commercialization experience in surgical instruments, with business operations spanning over 70 countries and regions and branch offices established across Asia, Europe, North America, and South America. The company’s domestically produced staplers have ranked first in export volume for seven consecutive years, with over 90% of its exported products sold under its own brand. Over the past three years, Pault Medical’s overseas revenue has achieved a compound annual growth rate (CAGR) exceeding 25%, making it one of the few Chinese brands in the minimally invasive surgical device sector to achieve a global commercial footprint.

Dai Jingmeng, Assistant to the General Manager of ITG Health Technology and Chairman of Perlove Medical, stated, “The completion of this acquisition marks Perlove Medical’s formal entry into ITG Corporation’s new health technology sector. Perlove Medical will gain stronger development momentum and new growth opportunities, accelerating its marketization, internationalization, and securitization.”

Mr. Qu Chao and Ms. Liu Qing, founders of Part Medical, stated: “The company has received strong support from numerous renowned investor partners through successive rounds of financing. With Guomao Health Technology becoming the controlling shareholder, we are not only optimizing the company’s top-level design but also injecting advantageous resources from a Fortune 500 enterprise. We believe that the new controlling shareholder will work hand in hand with the founding shareholders and management team to continue benefiting patients worldwide and jointly build Part Medical into a leading global enterprise in minimally invasive surgical devices.”

In the future, Palt Medical will continue to optimize and upgrade its stapler products, leveraging the advantages of intelligent electric staplers to capture a larger market share and solidify its leading position in China’s stapler industry. Meanwhile, the company will develop a one-stop surgical solution product line covering surgical access and visualization, tissue dissection and separation, as well as tissue resection and reconstruction. Building on its strengths in the minimally invasive surgery industry, Palt Medical will expand into surgical robot systems, creating an integrated smart minimally invasive surgery solution and establishing itself as a flagship enterprise in China’s domestically produced minimally invasive surgery sector.

Xiamen ITG Health Technology Co., Ltd. is a wholly-owned subsidiary of Xiamen ITG Group Corp., Ltd., a core enterprise under the Fortune Global 500-listed ITG Holding Group. Driven by innovative investment, ITG Health Tech integrates resources through an innovative development model and empowers its business with technology. The company has implemented a “2+2” business strategy, focusing on two pillar industries—medical devices and elderly care services—while synergizing two supporting industries—healthcare big data and health services. Leveraging five major capability centers, it aims to build a comprehensive health industry ecosystem. Committed to establishing collaborative links and platforms among enterprises, society, and the government, ITG Health Tech strives to become a trusted, China-leading, technology-enabled, integrated service provider in the broader health sector.

Beijing Pault Medical Technology Co., Ltd. is a leading provider of comprehensive surgical solutions in the industry. Focusing on the field of intelligent minimally invasive surgery, the company has established a comprehensive business system centered on stapler products, with full-scale development of other surgical instruments. Its business spans more than 70 countries and regions worldwide. With extensive commercialization experience in integrating global resources in the minimally invasive surgery industry, the company’s Chinese-made staplers have ranked No. 1 in export volume for seven consecutive years. It is one of the few domestic brands of minimally invasive surgical devices to achieve a global commercial footprint.